Share this article on:

TOUCH® Patient Reported Outcomes Study: The Impact of Natalizumab on Crohn's Disease Severity: P‐63

Lewis, James1; Nag, Arpita2; Taylor, Lori3; Hogge, Gary4; Colombel, Jean‐Frédéric5; Kane, Sunanda6; Panaccione, Remo7; Rubin, David8

Inflammatory Bowel Diseases: December 2012 - Volume 18 - Issue - p S41
Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13-15, 2012 Hollywood, Florida: Clinical Poster Presentations